Terry-Ann Burrell
Finanzdirektor/CFO bei BEAM THERAPEUTICS INC.
Vermögen: 2 Mio $ am 30.04.2024
Aktive Positionen von Terry-Ann Burrell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BEAM THERAPEUTICS INC. | Finanzdirektor/CFO | 01.08.2019 | - |
Treasurer | 01.09.2019 | - | |
RECURSION PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.04.2020 | - |
Independent Dir/Board Member | 01.04.2020 | - | |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 16.01.2024 | - |
Karriereverlauf von Terry-Ann Burrell
Ehemalige bekannte Positionen von Terry-Ann Burrell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01.05.2008 | 01.08.2019 |
Ausbildung von Terry-Ann Burrell
Harvard University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Treasurer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
BEAM THERAPEUTICS INC. | Health Technology |
RECURSION PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Terry-Ann Burrell
- Erfahrung